226 related articles for article (PubMed ID: 18762153)
1. Structure-activity relationships of macrolides against Mycobacterium tuberculosis.
Zhu ZJ; Krasnykh O; Pan D; Petukhova V; Yu G; Liu Y; Liu H; Hong S; Wang Y; Wan B; Liang W; Franzblau SG
Tuberculosis (Edinb); 2008 Aug; 88 Suppl 1():S49-63. PubMed ID: 18762153
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.
Falzari K; Zhu Z; Pan D; Liu H; Hongmanee P; Franzblau SG
Antimicrob Agents Chemother; 2005 Apr; 49(4):1447-54. PubMed ID: 15793125
[TBL] [Abstract][Full Text] [Related]
3. Antimycobacterial activity of diphenylpyraline derivatives.
Weis R; Faist J; di Vora U; Schweiger K; Brandner B; Kungl AJ; Seebacher W
Eur J Med Chem; 2008 Apr; 43(4):872-9. PubMed ID: 17714832
[TBL] [Abstract][Full Text] [Related]
4. In vitro and ex vivo activity of new derivatives of acetohydroxyacid synthase inhibitors against Mycobacterium tuberculosis and non-tuberculous mycobacteria.
Sohn H; Lee KS; Ko YK; Ryu JW; Woo JC; Koo DW; Shin SJ; Ahn SJ; Shin AR; Song CH; Jo EK; Park JK; Kim HJ
Int J Antimicrob Agents; 2008 Jun; 31(6):567-71. PubMed ID: 18337064
[TBL] [Abstract][Full Text] [Related]
5. A note on the antitubercular activities of 1-aryl-5-benzylsulfanyltetrazoles.
Adamec J; Waisser K; Kunes J; Kaustová J
Arch Pharm (Weinheim); 2005 Aug; 338(8):385-9. PubMed ID: 16041837
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationships of the quinolone antibacterials against mycobacteria: effect of structural changes at N-1 and C-7.
Renau TE; Sanchez JP; Gage JW; Dever JA; Shapiro MA; Gracheck SJ; Domagala JM
J Med Chem; 1996 Feb; 39(3):729-35. PubMed ID: 8576916
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of novel [1,2]-diamines with antituberculosis activity.
Meng Q; Luo H; Chen Y; Wang T; Yao Q
Bioorg Med Chem Lett; 2009 Sep; 19(18):5372-5. PubMed ID: 19682895
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationship of truncated analogs of caprazamycins as potential anti-tuberculosis agents.
Hirano S; Ichikawa S; Matsuda A
Bioorg Med Chem; 2008 May; 16(9):5123-33. PubMed ID: 18375127
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of new quinoxalin 1,4-dioxide derivatives against strains of Mycobacterium tuberculosis and other mycobacteria.
Zanetti S; Sechi LA; Molicotti P; Cannas S; Bua A; Deriu A; Carta A; Paglietti G
Int J Antimicrob Agents; 2005 Feb; 25(2):179-81. PubMed ID: 15664491
[No Abstract] [Full Text] [Related]
10. Synthesis, biological activity, and SAR of antimycobacterial 2- and 8-substituted 6-(2-furyl)-9-(p-methoxybenzyl)purines.
Braendvang M; Gundersen LL
Bioorg Med Chem; 2007 Nov; 15(22):7144-65. PubMed ID: 17804243
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and antimycobacterial activity of some novel imidazo[1,2-c]pyrimidines.
Chhabria MT; Jani MH
Eur J Med Chem; 2009 Oct; 44(10):3837-44. PubMed ID: 19423196
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, tuberculosis inhibitory activity, and SAR study of N-substituted-phenyl-1,2,3-triazole derivatives.
Costa MS; Boechat N; Rangel EA; da Silva Fde C; de Souza AM; Rodrigues CR; Castro HC; Junior IN; Lourenço MC; Wardell SM; Ferreira VF
Bioorg Med Chem; 2006 Dec; 14(24):8644-53. PubMed ID: 16949290
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of some new 1,4-dihydropyridines containing different ester substitute and diethyl carbamoyl group as anti-tubercular agents.
Khoshneviszadeh M; Edraki N; Javidnia K; Alborzi A; Pourabbas B; Mardaneh J; Miri R
Bioorg Med Chem; 2009 Feb; 17(4):1579-86. PubMed ID: 19162489
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, structure, and antimycobacterial activity of 6-[1(3H)-isobenzofuranylidenemethyl]purines and analogs.
Braendvang M; Bakken V; Gundersen LL
Bioorg Med Chem; 2009 Sep; 17(18):6512-6. PubMed ID: 19709890
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of indolizine derivatives with selective antibacterial activity against Mycobacterium tuberculosis.
Gundersen LL; Charnock C; Negussie AH; Rise F; Teklu S
Eur J Pharm Sci; 2007 Jan; 30(1):26-35. PubMed ID: 17079120
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of mycobacterial growth by plumbagin derivatives.
Mathew R; Kruthiventi AK; Prasad JV; Kumar SP; Srinu G; Chatterji D
Chem Biol Drug Des; 2010 Jul; 76(1):34-42. PubMed ID: 20456370
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antitubercular activity of novel 4-substituted imidazolyl-2,6-dimethyl-N3,N5-bisaryl-1,4-dihydropyridine-3,5-dicarboxamides.
Fassihi A; Azadpour Z; Delbari N; Saghaie L; Memarian HR; Sabet R; Alborzi A; Miri R; Pourabbas B; Mardaneh J; Mousavi P; Moeinifard B; Sadeghi-Aliabadi H
Eur J Med Chem; 2009 Aug; 44(8):3253-8. PubMed ID: 19371979
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of rifabutin analogs against Mycobacterium avium and H(37)Rv, MDR and NRP Mycobacterium tuberculosis.
Figueiredo R; Moiteiro C; Medeiros MA; da Silva PA; Ramos D; Spies F; Ribeiro MO; Lourenço MC; Júnior IN; Gaspar MM; Cruz ME; Curto MJ; Franzblau SG; Orozco H; Aguilar D; Hernandez-Pando R; Costa MC
Bioorg Med Chem; 2009 Jan; 17(2):503-11. PubMed ID: 19119013
[TBL] [Abstract][Full Text] [Related]
19. Antitubercular agents. Part 2: new thiolactomycin analogues active against Mycobacterium tuberculosis.
Kamal A; Shaik AA; Sinha R; Yadav JS; Arora SK
Bioorg Med Chem Lett; 2005 Apr; 15(7):1927-9. PubMed ID: 15780635
[TBL] [Abstract][Full Text] [Related]
20. Novel 4-(morpholin-4-yl)-N'-(arylidene)benzohydrazides: synthesis, antimycobacterial activity and QSAR investigations.
Raparti V; Chitre T; Bothara K; Kumar V; Dangre S; Khachane C; Gore S; Deshmane B
Eur J Med Chem; 2009 Oct; 44(10):3954-60. PubMed ID: 19464085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
